Owen Mumford
Owen Mumford Ltd, a leading name in the medical device industry, is headquartered in the United Kingdom (GB) and operates extensively across Europe, North America, and Asia. Founded in 1952, the company has established itself as a pioneer in the design and manufacture of innovative healthcare solutions, particularly in the fields of diabetes management and drug delivery systems. Renowned for its core products, including the Unifine® range of pen needles and the Autoject® injection devices, Owen Mumford focuses on enhancing patient comfort and compliance. The company’s commitment to quality and innovation has earned it a strong market position, with notable achievements in developing user-friendly devices that meet the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does Owen Mumford's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Owen Mumford's score of 55 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Owen Mumford's reported carbon emissions
In 2024, Owen Mumford reported total carbon emissions of approximately 41,249,000 kg CO2e. This figure includes Scope 1 emissions of about 166,000 kg CO2e, Scope 2 emissions of approximately 2,336,000 kg CO2e, and a significant contribution from Scope 3 emissions, which totalled around 38,747,000 kg CO2e. Owen Mumford has set ambitious climate commitments, aiming for a net-zero target across its entire value chain by FY2045. The company has established near-term targets to reduce absolute greenhouse gas emissions by 42% by FY2030, using FY2022 as the baseline. Furthermore, long-term goals include a substantial reduction of 90% in absolute emissions across all scopes by FY2045. These targets align with the Science Based Targets initiative (SBTi) and are designed to meet the necessary reductions to limit global warming to 1.5°C. Owen Mumford's commitment reflects a proactive approach to addressing climate change within the healthcare equipment and supplies sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 166,000 |
| Scope 2 | 2,336,000 |
| Scope 3 | 38,747,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Owen Mumford is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
